Safety and immunogenicity of the Chimpanzee-Adenovirus vectored Ebola vaccine: the Lausanne phase I/IIa clinical trial

被引：0

作者：

De Santis, O. ^{[1
]}

Audran, R. ^{[2
]}

Pothin, E. ^{[3
]}

Warpelin-Decrausaz, L. ^{[4
]}

Vallotton, L. ^{[4
]}

Wuerzner, G. ^{[4
]}

Cochet, C. ^{[1
]}

Estoppey, D. ^{[1
]}

Steiner-Monard, V. ^{[2
]}

Lonchampt, S. ^{[1
]}

Thierry, A. -C. ^{[2
]}

Mayor, C. ^{[2
]}

Bailer, R. T. ^{[5
]}

Mbaya, O. Tshiani ^{[5
]}

Zhou, Y. ^{[5
]}

Ploquin, A. ^{[5
]}

Sullivan, N. J. ^{[5
]}

Graham, B. S. ^{[5
]}

Roman, F. ^{[6
]}

De Ryck, I. ^{[6
]}

Ballou, R. ^{[6
]}

Kieny, M. P. ^{[7
]}

Moorthy, V. ^{[7
]}

Spertini, F. ^{[2
]}

Genton, B. ^{[1
,3
,8
]}

机构：

[1] Policlin Med Univ, Lausanne, Switzerland

[2] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland

[3] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland

[4] Univ Lausanne Hosp, Clin Trial Unit, Lausanne, Switzerland

[5] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA

[6] GSK Vaccines, Rixensart, Belgium

[7] WHO, CH-1211 Geneva, Switzerland

[8] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland

来源：

TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2015年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：43 / 43

页数：1

共 50 条

[1] Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Tapia, Milagritos D.
Sow, Samba O.
Mbaye, Khardiata D.
Thiongane, Aliou
Ndiaye, Birahim P.
Ndour, Cheikh T.
Mboup, Souleymane
Keshinro, Babajide
Kinge, Thompson N.
Vernet, Guy
Bigna, Jean Joel
Oguche, Stephen
Koram, Kwadwo A.
Asante, Kwaku P.
Gobert, Patrice
Hogrefe, Wayne R.
De Ryck, Iris
Debois, Muriel
Bourguignon, Patricia
Jongert, Erik
Ballou, William R.
Koutsoukos, Marguerite
Roman, Francois
[J]. LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 719 - 730
[2] Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Tapia, Milagritos D.
Sow, Samba O.
Ndiaye, Birahim P.
Mbaye, Khardiata D.
Thiongane, Aliou
Ndour, Cheikh T.
Mboup, Souleymane
Ake, Julie A.
Keshinro, Babajide
Akintunde, Gideon A.
Kinge, Thompson N.
Vernet, Guy
Bigna, Jean Joel
Oguche, Stephen
Koram, Kwadwo A.
Asante, Kwaku P.
Hogrefe, Wayne R.
Guenther, Stephan
Naficy, Abdi
De Ryck, Iris
Debois, Muriel
Bourguignon, Patricia
Jongert, Erik
Ballou, William R.
Koutsoukos, Marguerite
Roman, Francois
[J]. LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 707 - 718
[3] Chimpanzee adenovirus type 3 vectored Ebola vaccine: expanding the field
Bavari, Sina
Iversen, Patrick L.
[J]. LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 636 - 637
[4] Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
Borthwick, N. J.
Ahmed, T.
Rose, A.
Ebrahimsa, U.
Black, A.
Hayton, E.
Yang, H.
Hancock, G.
Campion, S.
Frahm, N.
Colloca, S.
Nicosia, A.
McMichael, A.
Dorrell, L.
Hanke, T.
[J]. RETROVIROLOGY, 2012, 9
[5] Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
NJ Borthwick
T Ahmed
A Rose
U Ebrahimsa
A Black
E Hayton
H Yang
G Hancock
S Campion
N Frahm
S Colloca
A Nicosia
A McMichael
L Dorrell
T Hanke
[J]. Retrovirology, 9
[6] Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and ChAdV-63 in a phase I/IIa clinical trial
Hanke, T.
Borthwick, N.
Ahmed, T.
Hayton, E. J.
Ebrahimsa, U.
Rose, A.
Black, A.
Yang, H.
Hancock, G.
Colloca, S.
Nicosia, A.
McMichael, A. J.
Dorrell, L.
[J]. IMMUNOLOGY, 2012, 137 : 517 - 518
[7] Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
Samy, Nathaly
Reichhardt, Daniela
Schmidt, Darja
Chen, Liddy M.
Silbernagl, Guenter
Vidojkovic, Sanja
Meyer, Thomas P. H.
Jordan, Elke
Adams, Tatiana
Weidenthaler, Heinz
Stroukova, Dania
De Carli, Sonja
Chaplin, Paul
[J]. VACCINE, 2020, 38 (11) : 2608 - 2619
[8] Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
George M Warimwe
Gema Lorenzo
Elena Lopez-Gil
Arturo Reyes-Sandoval
Matthew G Cottingham
Alexandra J Spencer
Katharine A Collins
Matthew DJ Dicks
Anita Milicic
Amar Lall
Julie Furze
Alison V Turner
Adrian VS Hill
Alejandro Brun
Sarah C Gilbert
[J]. Virology Journal, 10
[9] Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Warimwe, George M.
Lorenzo, Gema
Lopez-Gil, Elena
Reyes-Sandoval, Arturo
Cottingham, Matthew G.
Spencer, Alexandra J.
Collins, Katharine A.
Dicks, Matthew D. J.
Milicic, Anita
Lall, Amar
Furze, Julie
Turner, Alison V.
Hill, Adrian V. S.
Brun, Alejandro
Gilbert, Sarah C.
[J]. VIROLOGY JOURNAL, 2013, 10
[10] Safety and Immunogenicity of Novel Adenovirus Type 26-and Modified Vaccinia Ankara-Vectored Ebola Vaccines A Randomized Clinical Trial
Milligan, Iain D.
Gibani, Malick M.
Sewell, Richard
Clutterbuck, Elizabeth A.
Campbell, Danielle
Plested, Emma
Nuthall, Elizabeth
Voysey, Merryn
Silva-Reyes, Laura
McElrath, M. Juliana
De Rosa, Stephen C.
Frahm, Nicole
Cohen, Kristen W.
Shukarev, Georgi
Orzabal, Nicola
van Duijnhoven, Wilbert
Truyers, Carla
Bachmayer, Nora
Splinter, Daniel
Samy, Nathaly
Pau, Maria Grazia
Schuitemaker, Hanneke
Luhn, Kerstin
Callendret, Benoit
Van Hoof, Johan
Douoguih, Macaya
Ewer, Katie
Angus, Brian
Pollard, Andrew J.
Snape, Matthew D.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15): : 1610 - 1623

← 1 2 3 4 5 →